D-SPECT 衍生的心肌血流储备用于评估 STEMI 患者非罪犯缺血病变:与定量血流比值的比较
本研究纳入 106 例 STEMI 伴至少 1 处直径狭窄 40-80% 的中间非罪犯缺血病变患者,PCI 术后行 QFR 评估,约 5 天后行 D-SPECT 测定 MBF 和 MFR。以 QFR≤0.80 定义非罪犯缺血病变,MFR 预测的灵敏度 85%、特异度 86%、准确率 86%,cut-off 为 1.93,AUC 0.90(95%CI 0.84-0.94)。低 MFR 联合 AMR 可筛查和分层非罪犯缺血病变。
要点
- MFR 预测非罪犯病变 QFR≤0.80 的灵敏度 85%、特异度 86%、准确率 86%。
- MFR cut-off 为 1.93,AUC 0.90(95%CI 0.84-0.94),阳性预测值 56%、阴性预测值 96%。
- 低 MFR 伴正常 AMR 提示单纯心外膜狭窄所致缺血,低 MFR 伴异常 AMR 提示合并微血管功能障碍。
核心结论
- D-SPECT 衍生的 MFR 在识别 STEMI 患者非罪犯缺血病变方面表现出良好的诊断性能和中等一致性。
- MFR 联合 AMR 可有效筛查和分层非罪犯缺血病变。
研究设计与样本
- 本研究纳入 106 例 STEMI 伴至少 1 处直径狭窄 40-80% 的中间非罪犯缺血病变患者。
- 患者行 PCI 后接受 QFR 评估,约 5 天后行 D-SPECT 评估 MBF 和 MFR。
- 以 QFR≤0.80 定义非罪犯缺血病变,以 AMR<255 mmHg*s/m 定义微血管功能正常。
- 试验注册号 ChiCTR2200059934,注册日期 2022 年 5 月 13 日。
主要发现
- MFR 预测非罪犯病变 QFR≤0.80 的灵敏度 85%、特异度 86%、准确率 86%。
- 阳性预测值 56%,阴性预测值 96%。
- MFR cut-off 为 1.93,AUC 0.90(95%CI 0.84-0.94)。
- MFR 在微循环正常患者中表现出相似的诊断性能。
- 低 MFR 伴正常 AMR 提示单纯心外膜狭窄所致非罪犯缺血病变,低 MFR 伴异常 AMR 提示缺血病变合并微血管功能障碍。
关键数值与推荐
- 非罪犯缺血病变定义为 QFR≤0.80。
- 微血管功能正常定义为 AMR<255 mmHg*s/m。
- MFR 预测 QFR≤0.80 的 cut-off 为 1.93。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study sought to elucidate the diagnostic performance and concordance between myocardial flow reserve (MFR) derived from dynamic single-photon emission computed tomography (D-SPECT) and quantitative flow ratio (QFR) in evaluating non-culprit ischemic lesions following ST-elevation myocardial infarction (STEMI). Additionally, the study investigated the integration of MFR with angiographic microvascular resistance (AMR) derived from coronary angiography to determine its utility in screening and stratifying non-culprit ischemic lesions. BACKGROUND: The diagnostic performance and agreement between MFR and QFR in evaluating non-culprit ischemic lesions in STEMI patients with multivessel disease are unknown. METHODS: This research encompassed a cohort of 106 STEMI patients with at least 1 intermediate non-culprit ischemic lesion, characterized by 40-80% diameter stenosis. After undergoing percutaneous coronary intervention, patients were evaluated using QFR and, approximately five days later, underwent D-SPECT to assess myocardial blood flow (MBF) and MFR. MFR was evaluated against QFR as a reference for diagnostic performance and agreement, including sensitivity analysis in vessels with normal microvascular function. Furthermore, MFR, combined with AMR, effectively screened and stratified non-culprit ischemic lesions. Non-culprit ischemic lesions were defined by QFR ≤ 0.80 and normal microvascular function by AMR < 255 mmHg*s/m. RESULTS: Among non-culprit lesions, MFR predicted a QFR ≤ 0.80 with a sensitivity of 85%, specificity of 86%, and accuracy of 86%. The positive predictive value was 56%, and the negative predictive value was 96%. The MFR cut-off was 1.93, with an area under the receiver operating characteristic curve of 0.90 (95% CI: 0.84 to 0.94). MFR showed similar diagnostic performance in patients with normal microcirculation. Moreover, low MFR with normal AMR indicated non-culprit ischemic lesions caused solely by epicardial narrowing, while low MFR with abnormal AMR indicated ischemic lesions complicated by microvascular dysfunction. CONCLUSION: MFR derived from D-SPECT exhibits good diagnostic performance and moderate agreement in identifying non-culprit ischemic lesions in patients with STEMI. Combining AMR with MFR effectively screens and stratifies non-culprit ischemic lesions. TRIAL REGISTRATION: ChiCTR.org.cn. ChiCTR2200059934. Registered 13 May 2022.
引用
- Zhao M, Xing E, Zhao J, et al. Myocardial flow reserve derived from D-SPECT for evaluating non-culprit ischemic lesions in STEMI patients: comparison with quantitative flow ratio. Eur J Nucl Med Mol Imaging. 2025. PMID: 40237794. doi:10.1007/s00259-025-07223-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。